Medplus Health Services stock surges 4% after ICICI Prudential buys stake

Medplus Health Services stock surges 4% after ICICI Prudential buys stake



Medplus Health Services shares rose 4 per cent at Rs 663.50 per share on the NSE in Tuesday’s intraday trade. The stock price movement was followed by stake buyout by ICICI Prudential Mutual Fund on Monday. 


The public promoter of Medplus Health Services sold its entire stake worth Rs 836 crore through open market transactions on Monday. 


Lavender Rose Investment, a Mauritius-based unit of private equity firm Warburg Pincus, offloaded 1.35 crore shares, or 11.35 per cent of the Hyderabad-based pharmacy retailer, at Rs 616.48 each, according to NSE bulk deal data. 


ICICI Prudential India Opportunities Fund acquired 1.81 million shares for Rs 111.6 crore, while ICICI Prudential Pharma Healthcare and Diagnostics bought a 1.43 per cent stake at Rs 616 per share. Further, the Government of Singapore purchased 1.15 million shares at Rs 616.2 each.


Medplus Health Services provides pathological laboratory testing, and is involved in the manufacturing, trading, and contract manufacturing of pharmaceutical, FMCG, and beauty products. It also renders management services to group companies and holds investments in subsidiary companies.


The company has six direct subsidiaries and five step-down subsidiaries. For April-June quarter of financial year 2024-25 (Q1FY25), the company’s total income rose by 15.93 per cent year-on-year to Rs 1,488.83 crore. At the same time, operating profit or earnings before interest, tax, depreciation and amortisation (Ebitda) surged 78.21 per cent to Rs 33.73 crore on a Y-o-Y basis. 


Profit after tax soared by 279.37 per cent Y-o-Y  to Rs 14.36 crore. Operating margin improved by 53.73 per cent Y-o-Y to 2.27 per cent, while net profit margin rose 227.32 per cent Y-o-Y  to 0.96 per cent.


At 11:22 AM the shares of the company were trading 3.93 per cent higher at Rs 662.50 per share on NSE. By comparison the NSE Nifty50 was up 0.20 per cent at 25,061 levels. 

First Published: Aug 27 2024 | 11:35 AM IST



Source link

Alembic Pharma shares rise after USFDA drug approval; check details here

Alembic Pharma shares rise after USFDA drug approval; check details here



Shares of Alembic Pharmaceuticals soared up to 4.13 per cent at Rs 1,135 per share on the BSE in Tuesday’s early morning trade. This came after the company received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Betamethasone Valerate Foam, 0.12 per cent. 

 


Betamethasone valerate foam is used to treat scalp conditions such as psoriasis and seborrhea. Betamethasone, a corticosteroid, works by reducing inflammation, itching, and redness. The product is a generic equivalent of Luxiq Foam by Norvium Bioscience, LLC, the company said in an exchange filing on Monday. 

 


With this approval, Alembic’s total ANDA approvals from the US FDA now stands at 213, comprising 185 final approvals and 28 tentative approvals, the company said.

 


Q1FY25 show 


Alembic Pharmaceuticals reported an 11.5 per cent year-on-year increase in profit after tax (PAT) for the April-June quarter of financial year 2024-25 (Q1FY25), reaching Rs 134 crore, driven by strong performance in the US market. Revenue from operations grew 4.4 per cent year-on-year to Rs 1,563.8 crore in the June quarter. 

 


Sequentially, revenue increased by 2.8 per cent, but PAT fell 24.5 per cent. The Earnings before interest, tax, depreciation and amortisation (Ebitda) margin rose 14 per cent year-on-year to Rs 239 crore. 

 


The India Branded Business segment saw a 9 per cent increase, totaling Rs 572 crore, with notable growth in specialty therapies like gynaecology, gastrointestinal, anti-diabetic, and ophthalmology.

 


Despite this, heat waves in Q1FY25 caused market disruptions in certain regions. The Animal Health business grew 23 per cent for the quarter, supported by strong brands.

 


In the International Business segment, US Generics grew 18 per cent to Rs 461 crore, aided by two new US market launches. Ex-US International Formulations increased by 2 per cent to Rs 271 crore, and the company secured 206 cumulative abbreviated new drug application (ANDA) approvals.

 


At 10:22 AM the shares of the company pared all its gains, slipping in red, down 1.07 per cent at Rs 1078.25 per share. By comparison the BSE Sensex was up 0.07 per cent at 81,751 levels. 

First Published: Aug 27 2024 | 10:43 AM IST



Source link

KPI Green Energy jumps 4% after arm bags 13.30 MW solar power plant project

KPI Green Energy jumps 4% after arm bags 13.30 MW solar power plant project


KPI Green Energy shares in focus: Shares of KPI Green Energy rallied as much as 3.86 per cent to hit an intraday high of Rs 943 per share on Tuesday, August 27, 2024. 


The rise in KPI Green Energy share price came after the company announced that its wholly-owned subsidiary, Sun Drops Energia Private Limited, has received a 13.30 MW solar power plant project.


In an exchange filing, KPI Green Energy said, “We are pleased to announce that M/s. Sun Drops Energia Private Limited, a wholly owned subsidiary of KPI Green Energy Limited, has received Letters of Intent for executing solar power projects with a cumulative capacity of 13.30 MW under the ‘Captive Power Producer (CPP)’ business segment of the company.” 


The projects are scheduled to be completed in the financial year 2024-25, in various tranches as per the terms of the order, the company said.


Financial performance

 


KPI Green’s profit rose 98 per cent on a year-on-year (Y-o-Y) basis to Rs 66 crore in the June quarter of financial year 2025 (Q1FY25), from Rs 33 crore in the June quarter of financial year 2024 (Q1FY24).


The revenue from operations, or topline, rose 84 per cent Y-o-Y to Rs 348 crore in the June quarter of FY25, from Rs 189.3 crore in the June quarter of FY24. 


At the operating front, earnings before interest, tax, depreciation and amortisation (Ebitda), climbed 91 per cent annually to Rs 131.7 crore in Q1FY25, from Rs 69 crore inQ1FY24. 


Consequently, Ebitda margin expanded 150 basis points to 38 per cent in Q1FY25, from 36.5 per cent in Q1FY24. 


The company also declared its first interim dividend of Rs 0.20 per share for FY25.


Established in 2008, KPI Green Energy Ltd operates as a subsidiary of KP Group. Specialising in renewable energy, the company undertakes the complete lifecycle of solar and wind solar hybrid power projects. 


It functions both as an Independent Power Producer (IPP) and service provider for Captive Power Producers (CPPs) under its ‘Solarism’ brand, offering development, construction, ownership, management, and maintenance services for renewable power facilities.


The market capitalisation of this SmallCap company is Rs 12,010.33 crore, according to Bombay Stock Exchange (BSE). 


The 52-week high of the stock is Rs 1,116 while its 52-week low is Rs 255.46 per share.


At 9:29 AM, KPI Green Energy shares were trading 0.78 per cent higher at Rs 915 per share. In comparison, BSE Sensex was trading 0.04 per cent higher at 81,728.46 levels.

First Published: Aug 27 2024 | 9:34 AM IST



Source link

Stocks to Watch, Aug 27: Medi Assist, Bondada, Paytm, Repro India, Mazagon

Stocks to Watch, Aug 27: Medi Assist, Bondada, Paytm, Repro India, Mazagon



Stocks to Watch Today, Tuesday, August 27: Indian benchmark indices BSE Sensex and Nifty 50 are expected to open on a subdued note, as indicated by GIFT Nifty futures that were trading around 10 points behind Nifty futures. 




At 7:40 AM, GIFT Nifty futures were at 25,030, about 10 points lower that Nifty futures at 25,043.




That apart, the S&P 500 finished lower on Monday, with investors awaiting inflation data for clues on potential interest-rate cuts by the Federal Reserve. 




The S&P 500 declined 0.32 per cent to 5,616.84 points, the Nasdaq fell 0.85 per cent to 17,725.77 points, and the Dow Jones Industrial Average rose 0.16 per cent to 41,240.52 points.




Asia-Pacific markets largely fell on Tuesday morning, despite the Dow Jones Industrial Average reaching new highs. 




Japan’s Nikkei 225 was down 0.35 per cent, the broad-based Topix was flat, South Korea’s Kospi fell 0.42 per cent, and the small-cap Kosdaq saw a larger loss of 1.14 per cent. 




Australia’s S&P/ASX 200 was up 0.13 per cent, the only major Asia-Pacific index in positive territory, nearing its all-time closing high of 8,114.7 set on August 1. 


Hong Kong Hang Seng index futures were at 17,694, lower than the HSI’s last close of 17,798.73.

Meanwhile, here are some stocks to keep an eye on today:


UltraTech Cement: The company raised $500 million through a sustainability-linked loan with participation from six banks.




Bondada Engineering: The company received a Letter of Award for a project worth Rs 575.74 crore from Lumina Clean Energy, Purelight Energy, and VVKR Photovoltaics Energy, special purpose vehicles formed by Paradigm IT Technologies and Metalcraft Forming Industries.




Medi Assist Healthcare Services: The company’s subsidiary Medi Assist Insurance TPA signed definitive documents for the 100 per cent acquisition of Paramount Health Services & Insurance TPA from Fairfax Asia and the Shah family. This acquisition will grow Medi Assist’s TPA market share to 36.6 per cent for the group segment and 23.6 per cent of the health insurance industry by premiums managed.




PI Industries: The company appointed Sanjay Agarwal as Group Chief Financial Officer, effective August 26, following the retirement of Manikantan Viswanathan.




Paytm: The company Issued a clarification regarding recent media reports about a notice from SEBI. The company stated this is not a new development and had previously disclosed the matter in its financial results for the quarter and year ended March 31, 2024, and the quarter ended June 30, 2024.




Mazagon Dock Shipbuilders: Sanjeev Singhal, Director (Finance), has been entrusted with the additional charge of Chairman and Managing Director (CMD) for five months, effective August 1.




Repro India: Ashish Kacholia sold a 1.22 per cent stake in Repro India at an average price of Rs 625 per share. JVS Joyrass Holdings bought a 0.7 per cent stake at the same price.




Gland Pharma: One of the board of directors’ members, Qiyu Chen has not received security clearance from the Ministry of Home Affairs, Government of India, and will cease to continue as a Director, effective August 30.




AU Small Finance Bank: DSP Mutual Fund bought a 1.39 per cent stake in the company at an average price of Rs 630 per share. Fincare Business Services sold a 1.7 per cent stake at the same price.




Medplus Health Services: Lavender Rose Investment exited Medplus by selling its entire shareholding of 11.35 per cent at an average price of Rs 616.48 per share. ICICI Prudential Mutual Fund picked up a 4.3 per cent stake at an average price of Rs 616 per share, and the Government of Singapore bought a 0.97 per cent stake at an average price of Rs 616.2 per share.




GPT Infraprojects: The company launched its qualified institutions placement (QIP) issue on August 26, with the floor price fixed at Rs 183.83 per share.




HCL Technologies: The company extended its strategic AI-driven engineering services and digital process operations (DPO) partnership with Xerox. HCLTech will support the newly formed Xerox Global Business Services organization (GBS) in driving key business metrics.




Lemon Tree Hotels: The company signed a new property, Lemon Tree Hotel, Civil Lines, Ayodhya. The 80-room hotel is expected to open in FY28 and will be managed by its subsidiary, Carnation Hotels.




UCAL: The company signed a Memorandum of Understanding (MoU) with Blaer Motors to design and develop electronic components, including motor controllers ranging from 500 watts to 2 kilowatts.




MEP Infrastructure Developers: Elara India Opportunities Fund and Polus Global Fund exited MEP by selling a 1.09 per cent stake each at an average price of Rs 8.43 per share. Vani Agencies bought a 2.66 per cent stake at the same price.




KPI Green Energy: The company’s wholly-owned subsidiary, Sun Drops Energia Private Ltd, received letters of intent to execute solar power projects with a cumulative capacity of 13.30 MW under the captive power producer segment. Orders awarded by Sumicot, Ekta Prints Private, Radhika Fabrics, and Sanjopin Industries.




Vedanta: The company, led by Anil Agarwal, has prepared a Rs 30,000 crore war chest through recent funds raised via a qualified institutional placement (QIP), offer for sale (OFS), and dividend. The funds will be used for deleveraging, improving capital structure, and pursuing growth opportunities. Vedanta’s Q1 profit after tax grew 54 per cent YoY to Rs 5,095 crore. The company also recorded its highest-ever alumina production at Lanjigarh and reduced production costs by 20 per cent YoY. The mining major’s debt stood at Rs 6,130 crore as of June 302.




Alembic Pharmaceuticals: The company received USFDA approval for its generic Betamethasone Valerate Foam, used to treat moderate-to-severe psoriasis of the scalp. The approved ANDA is therapeutically equivalent to Luxiq Foam (0.12 per cent) by Norvium Bioscience3.




Godfrey Phillips: US-based proxy advisory firm Glass Lewis advised shareholders of Godfrey Phillips to vote against the reappointment of Bina Modi as Managing Director at the AGM on September 6. The firm cited concerns over her remuneration and lack of defined performance conditions. The company is currently experiencing a boardroom and succession battle between Bina Modi and her son, Samir Modi3.

TCS: Suresh Muthuswami, head of TCS’s $15 billion North American business, resigned in early August. Amit Bajaj, the president of the North American region, will take over his responsibilities. Under Muthuswami’s leadership, TCS’s North American business generated 51.1 per cent of the company’s $29.1 billion revenue for FY243.




YES Bank: The bank appointed Sumit Bali as the country head of debt management and retail assets. Bali will drive the growth and profitability of the bank’s retail and rural assets and debt management businesses. He previously held leadership roles at Axis Bank, India Infoline Group, and Kotak Mahindra Bank3.




Brightcom Group: The company reported a net loss of Rs 24.2 crore for the quarter ending December 30, 2023, with revenue declining by 85 per cent year-on-year to Rs 453.2 crore. The company attributed the poor performance to the war in Israel, the departure of its CEO and CFO, negative media coverage post-SEBI order, and multiple challenges faced by the board. The auditors flagged concerns over the interim financial statements and shareholding disclosures. Brightcom Group shares remain suspended for trading, and the company has yet to declare results for the March and June quarters.



Source link

World-beating Indian energy stocks' rally has fuel for more gains

World-beating Indian energy stocks' rally has fuel for more gains


The sector, dominated by India’s state-owned companies, has been an investor darling due to the country’s rapidly growing energy consumption | (Photo: Reuters)


By Chiranjivi Chakraborty

 


A bull run in India’s oil and gas companies may still have legs, underpinned by surging domestic demand and expectations of higher dividend payouts.

 


The Nifty Energy Index, a local benchmark for the industry, has risen 31 per cent this year, on course for a nine-year winning streak. In the period, a Bloomberg gauge of the world’s 124 mid- to large-sized energy firms has gained 4.7 per cent, with half of its top 10 performers being traditional energy firms from India.


The sector, dominated by India’s state-owned companies, has been an investor darling due to the country’s rapidly growing energy consumption, with the South Asian nation projected to be the leading driver of global demand through 2030. The optimism also stems from policy incentives to boost domestic oil and gas production, as well as increased cash payouts to shareholders.

Chart“In a market where earnings growth visibility is highly valued, and dividends are scarce, Indian energy companies stand out by offering attractive dividend yields,” said Vikas Pershad, portfolio manager at M&G Investments. “We maintain broad exposure to this sector and remain open to increasing our allocation to these companies.”
 


Major producer Oil India Ltd. is the industry’s top performing stock this year with a gain of 184 per cent. The company, along with Oil & Natural Gas Corp., has more earnings upside after India announced earlier this month that natural gas produced from new wells will enjoy a 20 per cent price premium, according to JM Financial.


Meanwhile, refiners are expected to benefit from improved margins in the next two quarters, while an ongoing building blitz to expand industry capacity will likely bring rewards in the long run.

“A combination of higher gross refining margins, range-bound crude, and stable fuel prices implies that the oil marketing companies’ integrated margins should improve sharply over 2Q-3Q,” Saurabh Handa, analyst at Citigroup Inc., wrote in a recent note.

Chart


The sector’s higher dividends are another attraction. The Nifty Energy Index’s projected 12-month dividend yield is 2.1 per cent, compared with 1.2 per cent for the benchmark Nifty 50, data compiled by Bloomberg show. 


To be sure, India’s heavy dependence on crude oil and natural gas imports also exposes its refiners to global price swings. In addition, the country’s efforts to accelerate a shift toward clean energy also bode ill for traditional energy firms. 


Still, foreign investors, who have turned less keen on India’s bubbly stock market this year, returned as net buyers of local energy firms in July after five straight months of selling, according to data from National Securities Depository Ltd. 


“We expect outperformance against both global peers and underlying commodities owing to hardware upgrades, free cash flow and higher-quality returns,” said Mayank Maheshwari, analyst at Morgan Stanley. “Early stages of re-rating were triggered by pricing power. The next stage should be driven by improved return quality and dividend surprises.”

First Published: Aug 27 2024 | 7:39 AM IST



Source link

Nifty PSU Bank may outperform in near-term; buy on dips strategy advised

Nifty PSU Bank may outperform in near-term; buy on dips strategy advised



Nifty Financial Services Index

The Nifty Financial Services Index is currently exhibiting a bullish trend on the charts. However, for fresh momentum to build up, the index needs to break out of its current trading range. This range is defined by the upper level at 23,500 and the lower level at 22,350. A breakout on either side of this range will likely trigger a significant movement in the index, offering trading opportunities based on the direction of the breakout. If the index breaks below the lower level of 22,350, it is expected to slip further, finding support at 23,100, 23,000, and 22,800. These support levels will be critical in determining whether the index can stabilise or if further downside is in store.

On the other hand, if the index breaks above the upper level of 23,500, it would signal a resumption of the bullish momentum. The next resistance levels to watch for in this scenario are 23,675, 23,800, and 24,000. Breaking through these resistance levels would further confirm the bullish outlook and could lead to additional upward movement in the index. 


Given the current technical setup, the best trading strategy would be to wait for a decisive breakout from this range. Traders should closely monitor the levels around 22,350 and 23,500. 


A confirmed breakout will provide a clearer direction for the market, enabling traders to make more informed decisions. It is advisable to keep a strict watch on these levels and be ready to act based on the breakout direction.


Nifty PSU Bank Index

 


The Nifty PSU Bank Index is showing an upward trend in the near term, despite experiencing a recent correction. This pullback should be viewed as an opportunity to accumulate the index and its constituent stocks at lower levels. The key support levels to focus on are 6,960, 6,900, and 6,825. These levels offer strategic entry points for traders and investors looking to capitalise on the anticipated outperformance of the index in the near term. 


The best trading strategy for the Nifty PSU Banks Index would be to adopt a “buy on dips” approach. The ongoing correction provides a favourable opportunity to enter the market at a discounted price, taking advantage of the upward trend. By purchasing the index and its constituents near the identified support levels, traders can position themselves to benefit from the expected recovery and subsequent upward movement. 


Once the index finds support and begins to rise, the next target levels to watch for are 7,100 and 7,200. These levels represent the resistance points where traders might consider booking profits, especially if the index shows signs of slowing down or encountering selling pressure. The overall bullish outlook suggests that the index and its constituent stocks are likely to outperform in the near term, making the “buy on dips” strategy particularly attractive.


(Disclaimer: Ravi Nathani is an independent technical analyst. Views are his own. He does not hold any positions in the Indices mentioned above and this is not an offer or solicitation for the purchase or sale of any security. It should not be construed as a recommendation to purchase or sell such securities.)

First Published: Aug 27 2024 | 6:23 AM IST



Source link

YouTube
Instagram
WhatsApp